An Impeccable Audience Quality to Ensure Meaningful Precision Medicine Connections

Just Confirmed to Attend

  • Tango Therapeutics
  • Sanofi
  • Novartis
  • Genmab
  • Arvinas
  • Tribune Therapeutics
  • Day One Biopharmaceuticals
  • Lahey Clinic

 

Teams Attending

  • Acrivon Therapeutics 8
  • AstraZeneca 8
  • Bristol Myers Squibb 24
  • Johnson & Johnson Innovative Medicines 25
  • Lahey Clinic 8
  • Merck 8
  • Novartis 11
  • Takeda 20

Senior Decision-Makers Joining Daily

  • Associate Director, Translational Clinical Research
  • Associate Director, Precision Medicine
  • Associate Vice President, Clinical Laboratory Sciences Oncology
  • Co-Director
  • Head, Exploratory Biomarker
  • Head, Precision Medicine
  • Senior Director, DMPK
  • Vice President & Head, Translational Sciences

Real-Time Industry Participation Trends

Biopharma leaders have already confirmed from 75+ drug developer organizations

With more than 40% of last year’s total pharma and biotech accounts secured in just 9 weeks, momentum is building fast

Brand-new companies attending include Adicet Bio, Alentis Therapeutics, Alnylam Pharmaceuticals, Celltrion and Ultragenyx

A highly targeted audience, with 73% of current 2026 attendees at Director/Head level or above

33+ industry-leading biopharma companies are sending team members from across the precision medicine value chain

Audience Breakdown

Take a sneak preview at the 850+ senior stakeholders joining us for the 16th World Clinical Biomarkers & Companion Diagnostics Summit.

Company Types
Types of Companies Attending
Seniority
Seniority of Attendees
Expertise & Job Titles
CDx Word Cloud (2)

*Statistics Taken from 15th World Clinical Biomarkers & Companion Diagnostics Summit

See the Full Event Line-Up